8-K current report · filed Oct 5, 2026

RXO, Inc. (RXO) 8-K Current Report: October 5, 2026

Item 1.01Item 8.01Item 5.02Item EX-99.1RXO overview

Short answer

RXO, Inc. (RXO) filed an 8-K current report with the SEC on October 5, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), Item 5.02 (Departure/Election of Directors or Officers), Item EX-99.1 (Exhibit EX-99.1). C.H. Robinson to acquire RXO, with closing expected first half of 2027, subject to shareholder, antitrust and SEC registration approvals.

RXO, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 1.01 · Entry into a Material Definitive Agreement

  • C.H. Robinson to acquire RXO, with closing expected first half of 2027, subject to shareholder, antitrust and SEC registration approvals
  • RXO holders choose $30.25 cash, 0.1992 C.H. Robinson shares, or standard $17.25 cash plus 0.0856 shares, with proration
  • RXO stockholder owning approximately 17.04% supports the transaction, strengthening approval certainty but remaining subject to recommendation changes
  • C.H. Robinson arranging up to $4.5 billion, 364-day bridge financing for cash consideration, refinancing and transaction expenses
  • RXO shares will be delisted from NYSE after closing, while C.H. Robinson shares remain NASDAQ-listed; termination fee $175 million in specified scenarios

Item 5.02 · Departure/Election of Directors or Officers

  • RXO directs investors to its 2026 proxy and 2025 Form 10-K for director and executive-officer ownership details
  • Insider ownership changes reflected through Forms 4, including filings by Wilkerson, Morris and Firestone
  • Proposed transaction materials will disclose participant interests and require careful review before voting or investing
  • Communication is not an offer, securities solicitation or request for shareholder approval

Item 8.01 · Other Events

  • October 5, 2026 press release announces the proposed RXO and C.H. Robinson transaction
  • Completion remains subject to stockholder and regulatory approvals, creating execution risk
  • C.H. Robinson plans Form S-4 registration statement and RXO proxy materials for the transaction
  • Transaction consideration may fluctuate with C.H. Robinson’s stock price
  • Key risks include debt financing, integration costs, synergy delivery and potential termination of the merger agreement

Item EX-99.1 · Exhibit EX-99.1

  • C.H. Robinson agreed to acquire RXO for implied consideration of $5.8B, creating a combined company exceeding $25B enterprise value
  • RXO holders receive $17.25 cash plus 0.0856 CHRW shares per share, implying $30.25 per RXO share and 27% premium to 90-day VWAP
  • Approximately $300M net run-rate cost synergies targeted within two years, creating meaningful margin and cash-flow upside if execution succeeds
  • RXO holders expected to own 11% of the combined company, with consideration structured as approximately 57% cash and 43% stock
  • Closing expected first half 2027, subject to regulatory and RXO shareholder approval; 17% holder MFN Partners committed to vote for the deal

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other RXO, Inc. 8-K filings

Get the next RXO 8-K as it lands

Follow RXO for push alerts, or ask the research agent what this filing means.